BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 32657324)

  • 1. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
    Viereck J; Bührke A; Foinquinos A; Chatterjee S; Kleeberger JA; Xiao K; Janssen-Peters H; Batkai S; Ramanujam D; Kraft T; Cebotari S; Gueler F; Beyer AM; Schmitz J; Bräsen JH; Schmitto JD; Gyöngyösi M; Löser A; Hirt MN; Eschenhagen T; Engelhardt S; Bär C; Thum T
    Eur Heart J; 2020 Sep; 41(36):3462-3474. PubMed ID: 32657324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA
    Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
    Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart.
    Hoepfner J; Leonardy J; Lu D; Schmidt K; Hunkler HJ; Biß S; Foinquinos A; Xiao K; Regalla K; Ramanujam D; Engelhardt S; Bär C; Thum T
    Mol Ther; 2022 Mar; 30(3):1265-1274. PubMed ID: 34856383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
    Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
    PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression.
    Nie X; Fan J; Wang Y; Xie R; Chen C; Li H; Wang DW
    Front Med; 2024 Jun; 18(3):484-498. PubMed ID: 38743133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA dysregulation in ischemic heart failure.
    Greco S; Zaccagnini G; Perfetti A; Fuschi P; Valaperta R; Voellenkle C; Castelvecchio S; Gaetano C; Finato N; Beltrami AP; Menicanti L; Martelli F
    J Transl Med; 2016 Jun; 14(1):183. PubMed ID: 27317124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19.
    Hobuß L; Foinquinos A; Jung M; Kenneweg F; Xiao K; Wang Y; Zimmer K; Remke J; Just A; Nowak J; Schmidt A; Pich A; Mazlan S; Reamon-Buettner SM; Ramos GC; Frantz S; Viereck J; Loyer X; Boulanger C; Wollert KC; Fiedler J; Thum T
    J Mol Cell Cardiol; 2020 Sep; 146():43-59. PubMed ID: 32649928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
    Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
    Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA cardiac hypertrophy-associated regulator governs cardiac hypertrophy via regulating miR-20b and the downstream PTEN/AKT pathway.
    Zhang M; Jiang Y; Guo X; Zhang B; Wu J; Sun J; Liang H; Shan H; Zhang Y; Liu J; Wang Y; Wang L; Zhang R; Yang B; Xu C
    J Cell Mol Med; 2019 Nov; 23(11):7685-7698. PubMed ID: 31465630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of lncRNA
    Yang L; Deng J; Ma W; Qiao A; Xu S; Yu Y; Boriboun C; Kang X; Han D; Ernst P; Zhou L; Shi J; Zhang E; Li TS; Qiu H; Nakagawa S; Blackshaw S; Zhang J; Qin G
    Theranostics; 2021; 11(16):7995-8007. PubMed ID: 34335976
    [No Abstract]   [Full Text] [Related]  

  • 14. A long noncoding RNA CHAIR protects the heart from pathological stress.
    Qian Y; Zhang M; Zhou N; Xu X; Zhang J; Ding Q; Wang J
    Clin Sci (Lond); 2020 Jul; 134(13):1843-1857. PubMed ID: 32643756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth.
    Li H; Trager LE; Liu X; Hastings MH; Xiao C; Guerra J; To S; Li G; Yeri A; Rodosthenous R; Silverman MG; Das S; Ambardekar AV; Bristow MR; González-Rosa JM; Rosenzweig A
    Circulation; 2022 Apr; 145(16):1218-1233. PubMed ID: 35114812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
    Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress.
    Awad S; Al-Haffar KM; Marashly Q; Quijada P; Kunhi M; Al-Yacoub N; Wade FS; Mohammed SF; Al-Dayel F; Sutherland G; Assiri A; Sussman M; Bers D; Al-Habeeb W; Poizat C
    J Pathol; 2015 Mar; 235(4):606-18. PubMed ID: 25421395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNAs in cardiac hypertrophy: From basic science to clinical application.
    Liu L; Zhang D; Li Y
    J Cell Mol Med; 2020 Oct; 24(20):11638-11645. PubMed ID: 32896990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA Chast promotes cardiac remodeling.
    Viereck J; Kumarswamy R; Foinquinos A; Xiao K; Avramopoulos P; Kunz M; Dittrich M; Maetzig T; Zimmer K; Remke J; Just A; Fendrich J; Scherf K; Bolesani E; Schambach A; Weidemann F; Zweigerdt R; de Windt LJ; Engelhardt S; Dandekar T; Batkai S; Thum T
    Sci Transl Med; 2016 Feb; 8(326):326ra22. PubMed ID: 26888430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.
    Wang Z; Zhang XJ; Ji YX; Zhang P; Deng KQ; Gong J; Ren S; Wang X; Chen I; Wang H; Gao C; Yokota T; Ang YS; Li S; Cass A; Vondriska TM; Li G; Deb A; Srivastava D; Yang HT; Xiao X; Li H; Wang Y
    Nat Med; 2016 Oct; 22(10):1131-1139. PubMed ID: 27618650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.